All Comments by Edward Koo

  1. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation.
  2. Postischemic hyperthermia induces Alzheimer-like pathology in the rat brain.
  3. Alpha-synuclein-immunoreactive deposits in human and animal prion diseases.
  4. Peeling plaque. Researchers remain optimistic about a vaccine against Alzheimer's.
  5. FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction.
  6. APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques.
  7. Molecular neuropathology of transgenic mouse models of Down syndrome.
  8. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.
  9. FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex.
  10. Preimplantation diagnosis for early-onset Alzheimer disease caused by V717L mutation.
  11. Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins.
  12. Environmental enrichment slows disease progression in R6/2 Huntington's disease mice.
  13. Role of the omentum in the treatment of Alzheimer's disease.
  14. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E.
  15. Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains.